You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain

    SBC: CrossComm, Inc.            Topic: NIDA

    Abstract One in five Americans has chronic pain. Many pharmacological pain interventions exist but increase risk of opioid use disorder (OUD). As a result, there is an urgent need for non-addictive pain treatments. One non- addictive pain treatments is neurofeedback, or electroencephalogram (EEG) biofeedback, which trains patients to regulate brain states linked to physiological relaxation. Neurof ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  2. A novel device for cervical insufficiency in pregnant women

    SBC: Cx Therapeutics, Inc            Topic: NICHD

    Abstract In normal pregnancy, the cervix remains closed until term and then dilates under the influence of uterine contractions. In cases of cervical insufficiency (CI), the cervix dilates in the second trimester in the absence of uterine contractions, which leads to a preterm birth. Infants born prematurely are at risk of lifelong morbidities including chronic lung disease, feeding difficulties, ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  3. Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements

    SBC: PASCALL Systems, Incorporated            Topic: NIDA

    PROJECT SUMMARY In light of the opioid crises, minimizing postoperative pain and postoperative opioid requirements to reduce chronic opioid dependency among surgical patients have become major concerns for surgeons and anesthesiologists. Effective intraoperative nociception control can mitigate these concerns. Unfortunately, existing nociceptive monitoring tools use indicators that are inherently ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  4. Multimode Organic Scintillators for Neutron/Gamma Detection

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: DTRA19B003

    There is significant interest in multi-functional materials enabling gamma-ray spectroscopy, neutron/gamma pulse shape discrimination (PSD), ultra-fast response, and time-of-flight (TOF) neutron detection. These materials would be used in a variety of mission scenarios for the localization and monitoring of special nuclear materials. Commercial inorganic scintillators offer some of these character ...

    STTR Phase I 2020 Department of DefenseDefense Threat Reduction Agency
  5. Semantic Models for the Identification of Laboratory Equipment (SMILE)

    SBC: CHARLES RIVER ANALYTICS, INC.            Topic: DTRA19B002

    Military operators must identify and catalogue the equipment they find when inspecting laboratory facilities. This information is used to determine the lab’s capabilities, including the lab’s potential for building weapons of mass destruction. Currently, operators use computer vision algorithms to help them classify equipment in pictures of laboratory environments. Unfortunately, current image ...

    STTR Phase I 2020 Department of DefenseDefense Threat Reduction Agency
  6. Rugged Ultrafast Radiation Hard Scintillators for Nuclear Battlefield

    SBC: CAPESYM INC            Topic: DTRA20B001

    Scintillator radiation detectors offer high sensitivity and relatively accurate radionuclide detection at a reasonable price. However, most of the available commercial scintillators have long decay times ranging from hundreds of nanoseconds to tens of microseconds. As a result, they have limited performance in high dose rate environments such as nuclear battlefields, robotic nuclear weapons test s ...

    STTR Phase I 2021 Department of DefenseDefense Threat Reduction Agency
  7. Fast and Radiation Hard Scintillators for High Dose Detection

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: DTRA20B001

    The event of nuclear explosion generates harsh radiation conditions, evaluation of which is critical in order to protect the military and civilian personnel from serious harm. Due to these harsh conditions only very simple methods of radiation assessment are employed, such as measurement of equivalent dose. Improvements to current instrumentation are sought that would provide energy resolved dose ...

    STTR Phase I 2021 Department of DefenseDefense Threat Reduction Agency
  8. HB-EGF regeneration to treat oral aphthous ulcers

    SBC: AURATION BIOTECH INC            Topic: NIDCR

    Project Summary / Abstract We request NIH support to develop heparin-binding epidermal growth factor-like growth factor (HB-EGF) as treatments for oral aphthous ulcer disease: Chronic recurrent oral aphthous ulcers are the most common type of inflammatory condition of the oral mucosa with a prevalence of 2% to 10% in Caucasian populations. They can be a manifestation of trauma or a systemic inflam ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  9. Development of selective calpain-1 inhibitors for chronic pain

    SBC: 1910 GENETICS INC.            Topic: 105

    PROJECT SUMMARY Never in the history of the United States has the unmet medical need to develop novel, non-opioid therapeutics for chronic pain been more urgent than it is today. More than 65 million US adults suffer from chronic pain, resulting in almost $635 billion in annual healthcare costs. Despite their limited efficacy, and potential for addiction, tolerance, and impaired motor performance, ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  10. Engineered adipokine receptor inhibitor for the treatment of triple negative breast cancer in obese patients

    SBC: Arrevus, Inc.            Topic: NCI

    PROJECT SUMMARYAn estimated 1 million cases of breast cancer (BC) are diagnosed annually worldwide. Of these, approximately 170,000 are triple-negative (ER-/PR-/HER2-) breast cancer (TNBC). TNBCs have an aggressive clinical course, worse prognosis, shorter disease-free interval, and worse overall survival compared to receptor positive breast cancers. Owing to the lack of target receptors, chemothe ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government